» Authors » Mahito Ozawa

Mahito Ozawa

Explore the profile of Mahito Ozawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 94
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Komatsu T, Tachibana H, Satoh Y, Ozawa M, Kunugita F, Nakamura M
Int Heart J . 2011 Feb; 52(1):32-8. PMID: 21321466
Little information is available concerning clinical profiles and outcomes of treatment in Japanese patients with first detected atrial fibrillation (AF). In the present study, 459 patients with paroxysmal AF (309...
12.
Yamasaki H, Tada H, Sekiguchi Y, Igarashi M, Arimoto T, Machino T, et al.
Heart Rhythm . 2011 Feb; 8(6):826-32. PMID: 21315839
Background: Even with a low energy setting, radiofrequency energy applications on the left atrial (LA) posterior wall may cause excessive transmural injury (ETI) during catheter ablation of atrial fibrillation (AF)....
13.
Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, et al.
Heart Rhythm . 2010 Nov; 8(3):335-41. PMID: 21056121
Background: Chronic kidney disease (CKD) is often associated with atrial fibrillation (AF). However, its impact on the results of radiofrequency catheter ablation for AF has not been fully examined. Objective:...
14.
Komatsu T, Tachibana H, Satoh Y, Ozawa M, Kunugida F, Nakamura M
Int Heart J . 2010 Oct; 51(5):331-6. PMID: 20966605
We examined the relationship between the efficacy of combined treatment with antiarrhythmic drugs (AAD) plus enalapril for maintaining sinus rhythm and circadian variation in the onset of paroxysmal AF.Three hundred...
15.
Komatsu T, Tachibana H, Satoh Y, Ozawa M, Kunugita F, Tashiro A, et al.
Circ J . 2010 Jul; 74(9):1859-65. PMID: 20631453
Background: It has been reported that approximately one-third of patients undergoing cardiovascular surgery experience paroxysmal atrial fibrillation (AF) during the postoperative period. There is, however, little information on the selection...
16.
Komatsu T, Tachibana H, Sato Y, Ozawa M, Kunugida F, Nakamura M
Int Heart J . 2010 Apr; 51(2):98-104. PMID: 20379042
We evaluated the efficacy of antiarrhythmic drug therapy (AAD) and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation (AF). This retrospective study included 334 patients (229 men and...
17.
Komatsu T, Tachibana H, Sato Y, Ozawa M, Kunugida F, Orii M, et al.
Int Heart J . 2009 Jul; 50(4):465-76. PMID: 19609051
The long-term efficacy of upstream therapy to prevent occurrence of paroxysmal atrial fibrillation (AF) in Japanese patients remains unclear. We retrospectively assessed the long-term efficacy of combination therapy with pravastatin...
18.
Komatsu T, Tachibana H, Sato Y, Ozawa M, Ohshima K, Orii M, et al.
J Cardiol . 2009 Jan; 53(1):35-42. PMID: 19167636
Methods And Results: This study included 68 patients (47 men, 21 women, mean age 69 years) in whom atrial fibrillation (AF) recurred immediately after electrical cardioversion (EC) was performed with...
19.
Komatsu T, Ozawa M, Tachibana H, Sato Y, Orii M, Kunugida F, et al.
Int Heart J . 2008 Aug; 49(4):435-47. PMID: 18753727
The purpose of this study was to examine the relationship between long-term efficacy of amiodarone therapy (100-200 mg/day) combined with angiotensin converting enzyme inhibitor (ACEI; enalapril 5 mg/day) administration, and...
20.
Komatsu T, Tachibana H, Sato Y, Ozawa M, Nakamura M, Okumura K
Circ J . 2006 Dec; 71(1):46-51. PMID: 17186977
Background: It has been previously reported that the efficacy of class I antiarrhythmics in preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation (AF) is limited when AF lasts...